AML2003 - Standard-Therapy vs Intensified Therapy for Adult Acute Myeloid Leukemia Patients <= 60 Years
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
AML2003 is a prospective randomized trial, to investigate the value of early allogeneic stem
cell transplantation in aplasia after induction therapy for high risk patients with acute
myeloid leukemia.